~~<i id='5B98F994B2'><strike id='5B98F994B2'><tt id='5B98F994B2'><pre id='5B98F994B2'></pre></tt></strike></i>~~

Home» Wikipedia» leisure time

leisure time

author：knowledge 2025-10-06 18:43:46 Page View：92

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： GSK Flovent asthma inhalers replaced by authorized generics
Next article： Supreme Court strikes down use of affirmative action

explore

The high cost of giving birth even with insurance

AdobeTheburdenofhighhealthcarecostsandmedicaldebtintheU.S.isnosecret.Medicaldebtaffectsoneinfiveadul

Goldman Sachs launches $650M fund for life science investments

AdobeInvestmentbankGoldmanSachsisjumpingintothebiotechworldafterraising$650milliontoinvestinprivatel

Continuity nursing helped my family in our darkest PICU moments

EssayauthorSarahMcCarthycuddleswithherdaughterMolly.CourtesySarahMcCarthyTheventilatoralarmwokemeat3

Federal weight loss drug coverage is 30 years out of date

ApharmacistholdsaboxofWegovyatapharmacyinProvo,Utah.BloombergphotobyGeorgeFreyFewmedicationshavecapt